Category: Press Releases (3)
Novocell Awarded Seminal Stem Cell Patent
San Diego, CA (March 31, 2009) – Novocell, Inc., a stem cell engineering company, today announced that it has received U.S. Patent 7,510,876 with claims covering human definitive endoderm cells, an essential cell for generating not only pancreatic type cells, which Novocell is developing for use as a cell therapy for diabetes, but also other endoderm lineage-derived tissues and organs...
StemCellPatents.com Applauds ISCO
StemCellPatents.com Applauds International Stem Cell Corporation (ISCO) On Recent Developments San Diego, CA - Medistem Inc has announced in the press release below that it has filed an Investigational New Drug (IND) application with the FDA for use of its Endometrial Regenerative Cells (ERC) for the treatment of critical limb ischemia. The Principle Investigator for the proposed study Dr. Michael Murphy from Indiana University has previously...
ISCO First To Grow Human Corneal Tissue From Stem Cells, Entering Pre-Clinical Trials For Retinal Disease & Improved Forms of Corrective Laser Eye...
Medistem Files IND for Endometrial Regenerative Cells